Clinical Trials Browser

Phase 2 × Aprepitant × Other hematologic neoplasm × Clear all

NCT01334086 2021-11-22

Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy

Phase 2 Completed

41 enrolled 10 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00954941 2015-06-25

Ondansetron Versus Aprepitant Plus Ondansetron for Emesis

Phase 2 Completed

100 enrolled 7 charts

MyeloidOther hematologic neoplasm

Hematologic Diseases, Myelodysplastic Syndromes, Nausea, Vomiting, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute